UB Paderborn / Katalog / Suche / in CDI

Aggression in autism spectrum disorder: presentation and treatment options

Neuropsychiatric disease and treatment, 2016-01, Vol.12, p.1525-1538

2016

Link zum Volltext

Verfügbarkeit prüfen

A Systematic Review of Treatments for Anxiety in Youth with Autism Spectrum Disorders

Journal of autism and developmental disorders, 2014-12, Vol.44 (12), p.3215-3229

2014

Link zum Volltext

Verfügbarkeit prüfen

Fragile X targeted pharmacotherapy: lessons learned and future directions

Journal of neurodevelopmental disorders, 2017-06, Vol.9 (1), p.7-7, Article 7

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome

Psychopharmacology, 2013-07, Vol.228 (1), p.75-84

2013

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents

Paediatric drugs, 2020-10, Vol.22 (5), p.473-483

2020

Link zum Volltext

Verfügbarkeit prüfen

Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder—Initial Results of a Randomized, Controlled, Crossover, Pilot Study

Journal of autism and developmental disorders, 2021-04, Vol.51 (4), p.1392-1399

2021

Link zum Volltext

Verfügbarkeit prüfen

Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder

Journal of child and adolescent psychopharmacology, 2016-11, Vol.26 (9), p.822

2016

Link zum Volltext

Verfügbarkeit prüfen

Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: A chart review study

Autism : the international journal of research and practice, 2015-01, Vol.19 (1), p.102-106

2015

Link zum Volltext

Verfügbarkeit prüfen

Lymphocytic Extracellular Signal–Regulated Kinase Dysregulation in Autism Spectrum Disorder

Journal of the American Academy of Child and Adolescent Psychiatry, 2023-05, Vol.62 (5), p.582-592.e2

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis

Journal of autism and developmental disorders, 2019-11, Vol.49 (11), p.4595-4602

2019

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder

Journal of autism and developmental disorders, 2018-11, Vol.48 (11), p.3711-3719

2018

Link zum Volltext

Verfügbarkeit prüfen

Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole

Journal of child and adolescent psychopharmacology, 2014-03, Vol.24 (2), p.78

2014

Link zum Volltext

Verfügbarkeit prüfen

Brief Report: Diminished Gaze Preference for Dynamic Social Interaction Scenes in Youth with Autism Spectrum Disorders

Journal of autism and developmental disorders, 2017-02, Vol.47 (2), p.506-513

2017

Link zum Volltext

Verfügbarkeit prüfen

Brief Report: Metformin for Antipsychotic-Induced Weight Gain in Youth with Autism Spectrum Disorder

Journal of autism and developmental disorders, 2017-07, Vol.47 (7), p.2290-2294

2017

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorder

Journal of autism and developmental disorders, 2018-09, Vol.48 (9), p.3051-3060

2018

Link zum Volltext

Verfügbarkeit prüfen

A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder

Journal of child and adolescent psychopharmacology, 2015-06, Vol.25 (5), p.397

2015

Link zum Volltext

Verfügbarkeit prüfen

Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study

Journal of neurodevelopmental disorders, 2019-01, Vol.11 (1), p.1-1, Article 1

2019

Link zum Volltext

Verfügbarkeit prüfen

A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders

Molecular autism, 2016-01, Vol.7 (3), p.2, Article 2

2016

Link zum Volltext

Verfügbarkeit prüfen

A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder

Molecular autism, 2016-04, Vol.7 (26), p.26, Article 26

2016

Link zum Volltext

Verfügbarkeit prüfen

Pediatric Quality of Life Inventory (PedsQL) in Fragile X Syndrome

Journal of autism and developmental disorders, 2020-03, Vol.50 (3), p.1056-1063

2020

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic differences in individuals with autism spectrum disorder born preterm and at term gestation

Autism : the international journal of research and practice, 2015-08, Vol.19 (6), p.758-763

2015

Link zum Volltext

Verfügbarkeit prüfen

Lurasidone for the treatment of irritability and anger in autism spectrum disorders

Expert opinion on investigational drugs, 2017-08, Vol.26 (8), p.985-989

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of acamprosate on plasma amyloid-β precursor protein in youth: A pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker

Journal of psychiatric research, 2014-12, Vol.59, p.220-228

2014

Link zum Volltext

Verfügbarkeit prüfen

A prospective open-label study of aripiprazole in fragile X syndrome

Psychopharmacologia, 2011-07, Vol.216 (1), p.85-90

2011

Link zum Volltext

Verfügbarkeit prüfen

Initial analysis of peripheral lymphocytic extracellular signal related kinase activation in autism

Journal of psychiatric research, 2017-01, Vol.84, p.153-160

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Aggression in autism spectrum disorder: presentation and treatment options

A Systematic Review of Treatments for Anxiety in Youth with Autism Spectrum Disorders

Fragile X targeted pharmacotherapy: lessons learned and future directions

Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome

Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents

Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder—Initial Results of a Randomized, Controlled, Crossover, Pilot Study

Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder

Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: A chart review study

Lymphocytic Extracellular Signal–Regulated Kinase Dysregulation in Autism Spectrum Disorder

Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis

Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder

Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole

Brief Report: Diminished Gaze Preference for Dynamic Social Interaction Scenes in Youth with Autism Spectrum Disorders

Brief Report: Metformin for Antipsychotic-Induced Weight Gain in Youth with Autism Spectrum Disorder

A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorder

A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder

Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study

A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders

A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder

Pediatric Quality of Life Inventory (PedsQL) in Fragile X Syndrome

Phenotypic differences in individuals with autism spectrum disorder born preterm and at term gestation

Lurasidone for the treatment of irritability and anger in autism spectrum disorders

Impact of acamprosate on plasma amyloid-β precursor protein in youth: A pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker

A prospective open-label study of aripiprazole in fragile X syndrome

Initial analysis of peripheral lymphocytic extracellular signal related kinase activation in autism

Suchergebnisse filtern